SOUTH SAN FRANCISCO, Calif. (AP) _ Cytokinetics Inc. (CYTK) on Tuesday reported a loss of $30.6 million in its fourth quarter.
The South San Francisco, California-based company said it had a loss of 52 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.
The biopharmaceutical company posted revenue of $5.2 million in the period.
For the year, the company reported that its loss widened to $121.7 million, or $2.11 per share. Revenue was reported as $26.9 million.
Cytokinetics shares have risen 39% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $14.75, more than doubling in the last 12 months.